Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Wojciech Legieć
Review New Drugs in Multiple Myeloma – Role of Carfilzomib and Pomalidomide
Wspolczesna Onkologia
Oncology
Radiology
Nuclear Medicine
Imaging
Related publications
Orphan Designation: Pomalidomide, Treatment of Multiple Myeloma
Case Medical Research
Emerging Role of Carfilzomib in Treatment of Relapsed and Refractory Lymphoid Neoplasms and Multiple Myeloma
Core Evidence
Medicine
Reviews
References
Pharmacology
Carfilzomib for Relapsed or Refractory Multiple Myeloma
The Lancet Oncology
Oncology
Cost-Effectiveness of Pomalidomide, Carfilzomib, and Daratumumab for the Treatment of Patients With Heavily Pretreated Relapsed–refractory Multiple Myeloma in the United States
Clinical Therapeutics
Pharmacology
Pomalidomide and Myeloma Meningitis
Leukemia and Lymphoma
Cancer Research
Oncology
Hematology
Bendamustine, Pomalidomide, and Dexamethasone for Relapsed and/or Refractory Multiple Myeloma
Blood Cancer Journal
Oncology
Hematology
Productivity Costs Related to Bortezomib and Carfilzomib Administration for Multiple Myeloma in Finland
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Efficacy of Carfilzomib, Lenalidomide, and Dexamethasone for Extramedullary Intracranial Localization of Multiple Myeloma
Case Reports in Hematology
Isatuximab Plus Carfilzomib/Dexamethasone Versus Carfilzomib/Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma: IKEMA Phase III Study Design
Future Oncology
Medicine
Cancer Research
Oncology